The life sciences industry is in a state of evolution. Biotech breakthroughs and consumer health trends are fueling growth, but legal departments face rising litigation, shifting regulations, and tighter budgets—demanding more strategic, cost-effective operations.
So how are legal teams protecting innovation, managing risk, and driving value without letting costs spiral?
In this new report, we delve into the legal departments of today’s leading life sciences companies. Through a third-party blind survey of over 100 senior legal and operations leaders—including CLOs, GCs, and legal directors—we examine the key challenges and priorities shaping legal ops, IP strategy, and litigation management across the industry.
Download the report to uncover insights such as:
- The top legal ops initiatives driving efficiency and productivity
- Why 59% of IP teams now have defensive strategies against NPEs
- Expert insights from senior counsel at global healthcare leaders
- Benchmark data on AI adoption, eDiscovery models, and more
See how leading legal teams are shifting from cost centers to strategic partners in the business of science.
